Skip to main content
SpringerLink
Log in

Some Aspects of Quality Risk Management for the Fenspiride Hydrochloride (0.08 G Coated Tablets) Production Process at the Pharmaceutical Development Stage

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The urgency to satisfy pharmaceutical regulatory requirements, including drug quality risk management, prompted the application of risk assessment methodology during the pharmaceutical development (PD) stage of an actual drug production process to be studied. Risk assessment results for the industrial process in combination with information regarding risks to the final product that were obtained during the PD allowed an objective opinion about the influence of the product properties and process parameters on critical drug quality parameters during its mass production to be formulated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Guideline ST-N MOZU 42-3.0:2011. Drugs. Pharmaceutical Development [in Ukrainian] (ICH Q8), MOZU, Kyiv (2011).

  2. Guideline ST-N MOZU 42-4.2:2011. Drugs. Quality Risk Management [in Ukrainian] (ICH Q9), MOZU, Kyiv (2011).

  3. Guideline ST-N MOZU 42-4.0:2013. Drugs. Good Manufacturing Practice [in Ukrainian], MOZU, Kyiv (2013).

  4. S. N. Kashutskii, S. V. Rusanova, and S. I. Dikhtyarev, Farmakom, No. 3, 54 – 62 (2013).

  5. S. N. Kashutskii, S. V. Rusanova, S. I. Dikhtyarev, et al., in: Proceedings of the IVth All-Russian Scientific-Practical Conference with International Participation [in Russian], Vladikavkaz (2014), pp. 106 – 109.

  6. S. N. Kashutskii, S. V. Rusanova, S. I. Dikhtyarev, et al., in: Proceedings of the IVth All-Russian Scientific-Practical Conference with International Participation [in Russian], Vladikavkaz (2014), pp. 110 – 112.

  7. GOST R 51901.12-2007 [IEC 60812:2006, Risk management.

  8. Procedure for failure mode and effects analysis (FMEA), MOD], Moscow (2008).

  9. GOST R ISO / IEC 31010-2011 (ISO / IEC 31010:2009, Risk management. Risk assessment methods, IDT), Moscow (2012).

Download references

Author information

Authors and Affiliations

  1. Interchem Co., Odessa, Ukraine

    S. N. Kashutskii

  2. National Pharmaceutical University, Institute of Post-Graduate Education and Training, Kharkiv, Ukraine

    S. V. Rusanova, S. I. Dikhtyarev & A. V. Dorovskoi

Authors
  1. S. N. Kashutskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. V. Rusanova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. I. Dikhtyarev
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. V. Dorovskoi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 49, No. 11, pp. 49 – 53, November, 2015.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kashutskii, S.N., Rusanova, S.V., Dikhtyarev, S.I. et al. Some Aspects of Quality Risk Management for the Fenspiride Hydrochloride (0.08 G Coated Tablets) Production Process at the Pharmaceutical Development Stage. Pharm Chem J 49, 771–775 (2016). https://doi.org/10.1007/s11094-016-1368-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-016-1368-3

Keywords

Search

Navigation